AVIVA Biosciences is a contract research organization providing safety screening with emphasis on ion channels. It invents devices and assays to advance the study of eukaryotic cells. The company also develops a RedSift cell processor that separates cells of interest from plasma, thrombocytes, erythrocytes, and any unbound particles or biotes.